13F filer · CIK 1513038 ↗
Perkins Coie Trust Co
You are looking at Q4 2017. See the latest, Q3 2026 →
Reported value
$200.2M
+4.0% on the quarter before
Positions
329
2 new · 3 sold out
Top 10
30.4%
of the value
Est. gain
+$9.7M
on stocks held all quarter
Est. return
+5.2%
on those stocks since Q3 2017
Positions as of Dec 31, 2017, from Perkins Coie Trust Co's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 51% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2017. Striped tiles are options.
Largest buys
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares California Muni Bond ETF~$532,000New · 0.0% → 0.3%+9,000 shares
- General Electric Co~$379,145Added · 0.7% → 0.7%+21,741 shares
- Medtronic Plc~$70,819Added · 1.1% → 1.1%+877 shares
- Cloudera Inc Usd 0.00005~$59,000New · 0.0% → 0.0%+3,558 shares
- Pepsico Inc~$52,161Added · 1.6% → 1.7%+435 shares
- Air Products & Chemicals Inc~$47,098Added · 0.8% → 0.8%+287 shares
- Chubb Limited~$45,889Added · 1.2% → 1.2%+314 shares
- Walt Disney Company (The)~$44,833Added · 1.4% → 1.5%+417 shares
- Pfizer Inc~$38,037Added · 1.3% → 1.3%+1,050 shares
- Tjx Companies Inc~$37,076Added · 1.0% → 1.0%+485 shares
Largest sells
Since Q3 2017, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Ishares S&P 500 Growth~$1.0MCut · 7.5% → 7.2%−6,574 shares
- Microsoft~$449,698Cut · 3.7% → 3.9%−5,257 shares
- SPDR S&P Biotech ETF~$399,053Cut · 1.7% → 1.4%−4,702 shares
- Baker Hughes~$104,817Cut · 0.3% → 0.2%−3,314 shares
- Vf Corp~$81,690Cut · 0.9% → 1.0%−1,104 shares
- Apple~$76,669Cut · 2.1% → 2.2%−453 shares
- Exxon Mobil Corp~$76,246Cut · 0.4% → 0.4%−912 shares
- Vanguard Small Cap ETF~$74,877Cut · 0.3% → 0.3%−507 shares
- Abbvie Inc~$72,422Cut · 1.1% → 1.1%−749 shares
- Ishares S&P Midcap 400 Growth~$56,762Cut · 4.5% → 4.6%−263 shares
Holdings
As of Dec 31, 2017. Changes are in shares against Sep 30, 2017, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Ishares S&P 500 GrowthEQUITY - LARGE CAP - ETF · shares −6.5% · price +6.5% | 7.2% | $14.4M | +$882,833 | ||||||||
| Ishares S&P Midcap 400 GrowthEQUITY - MIDCAP - ETF · shares −0.6% · price +6.7% | 4.6% | $9.2M | +$576,222 | ||||||||
| MicrosoftCOMMON STOCK · shares −5.5% · price +14.8% | 3.9% | $7.7M | +$1.0M | ||||||||
| 3m CoCOMMON STOCK · shares −0.3% · price +12.1% | 3.5% | $7.1M | +$765,991 | ||||||||
| AppleCOMMON STOCK · shares −1.7% · price +9.8% | 2.2% | $4.5M | +$398,814 | ||||||||
| Home Depot IncCOMMON STOCK · shares −1.1% · price +15.9% | 1.9% | $3.9M | +$530,801 | ||||||||
| Vanguard S&P 500 ETFEQUITY - LARGE CAP - ETF · shares −0.6% · price +6.3% | 1.9% | $3.8M | +$222,770 | ||||||||
| Procter & Gamble CoCOMMON STOCK · shares +0.8% · price +1.0% | 1.8% | $3.5M | +$34,509 | ||||||||
| Pepsico IncCOMMON STOCK · shares +1.6% · price +7.6% | 1.7% | $3.4M | +$236,839 | ||||||||
| Unitedhealth Group IncCOMMON STOCK · shares −1.0% · price +12.6% | 1.7% | $3.4M | +$378,378 | ||||||||
| Pnc Financial Services GroupCOMMON STOCK · shares −0.3% · price +7.1% | 1.6% | $3.3M | +$215,645 | ||||||||
| CiscoCOMMON STOCK · shares +0.4% · price +13.9% | 1.6% | $3.2M | +$391,828 | ||||||||
| Wells Fargo & CoCOMMON STOCK · shares −1.5% · price +10.0% | 1.5% | $3.1M | +$281,678 | ||||||||
| Chevron CorpCOMMON STOCK · shares −0.4% · price +6.5% | 1.5% | $3.1M | +$187,924 | ||||||||
| Walt Disney Company (The)COMMON STOCK · shares +1.5% · price +9.1% | 1.5% | $3.1M | +$250,167 | ||||||||
| Visa Inc.COMMON STOCK · shares +0.4% · price +8.3% | 1.5% | $3.0M | +$226,284 | ||||||||
| BlackRockCOMMON STOCK · shares +0.9% · price +14.9% | 1.5% | $3.0M | +$379,258 | ||||||||
| Charles Schwab CorpCOMMON STOCK · shares +1.0% · price +17.4% | 1.5% | $2.9M | +$432,219 | ||||||||
| Ishares S&P Midcap 400 GrowthEQUITY - MIDCAP - ETF · shares 0% · price +6.7% | 1.4% | $2.9M | +$179,000 | ||||||||
| Stryker CorpCOMMON STOCK · shares −1.5% · price +9.0% | 1.4% | $2.8M | +$235,193 | ||||||||
| SPDR S&P Biotech ETFEQUITY SECTOR - ETF · shares −12% · price −2.0% | 1.4% | $2.8M | −$55,960 | ||||||||
| IntelCOMMON STOCK · shares +0.00% · price +21.2% | 1.4% | $2.8M | +$484,954 | ||||||||
| The Travelers Co IncCOMMON STOCK · shares 0% · price +10.7% | 1.4% | $2.8M | +$268,000 | ||||||||
| Comcast CorpCOMMON STOCK · shares +1.0% · price +4.1% | 1.4% | $2.7M | +$106,650 | ||||||||
| Danaher CorpCOMMON STOCK · shares +0.5% · price +8.2% | 1.3% | $2.7M | +$203,841 | ||||||||
| Total · 329 positions | 100% | $200.2M | +$9.7M |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2017 to Q4 2017: 323 stocks held throughout, up $9.7M (+5.2%).
- Microsoft+$1.0M+15%
- Ishares S&P 500 Growth+$882,833+7%
- 3m Co+$765,991+12%
- Ishares S&P Midcap 400 Growth+$576,222+7%
- Home Depot Inc+$530,801+16%
- Merck & Co Inc−$60,000−12%
- Baker Hughes−$66,664−14%
- Cvs Health Corp−$240,208−11%
- General Electric Co−$363,145−28%
- Graco Inc−$2.7M−63%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q3 2026 | Oct 14, 2026 | $625.7M+4% | SEC ↗ |
| Q2 2026 | Jul 9, 2026 | $603.3M+16% | SEC ↗ |
| Q1 2026 | Apr 15, 2026 | $520.1M−3% | SEC ↗ |
| Q4 2025 | Jan 12, 2026 | $537.0M+1% | SEC ↗ |
| Q3 2025 | Oct 9, 2025 | $531.5M−9% | SEC ↗ |
| Q2 2025 | Jul 10, 2025 | $587.1M+33% | SEC ↗ |
| Q1 2025 | Apr 11, 2025 | $441.0M−3% | SEC ↗ |
| Q4 2024 | Jan 16, 2025 | $454.4M+1% | SEC ↗ |
| Q3 2024 | Oct 8, 2024 | $450.9M+5% | SEC ↗ |
| Q2 2024 | Jul 15, 2024 | $430.1M+1% | SEC ↗ |
| Q1 2024 | Apr 12, 2024 | $426.7M+8% | SEC ↗ |
| Q4 2023 | Jan 9, 2024 | $396.1M+12% | SEC ↗ |
| Q3 2023 | Oct 11, 2023 | $354.4M+1% | SEC ↗ |
| Q2 2023 | Jul 14, 2023 | $352.1M+5% | SEC ↗ |
| Q1 2023 | Apr 13, 2023 | $333.8M+7% | SEC ↗ |
| Q4 2022 | Jan 18, 2023 | $312.8M+20% | SEC ↗ |
| Q3 2022 | Oct 7, 2022 | $260.9M−5% | SEC ↗ |
| Q2 2022 | Jul 8, 2022 | $274.7M−15% | SEC ↗ |
| Q1 2022 | Apr 15, 2022 | $322.1M−6% | SEC ↗ |
| Q4 2021 | Jan 13, 2022 | $341.1M+7% | SEC ↗ |
| Q3 2021 | Oct 13, 2021 | $319.7M−2% | SEC ↗ |
| Q2 2021 | Jul 14, 2021 | $324.9M+8% | SEC ↗ |
| Q1 2021 | Apr 13, 2021 | $300.0M+2% | SEC ↗ |
| Q4 2020 | Jan 12, 2021 | $293.0M+17% | SEC ↗ |
| Q3 2020 | Oct 13, 2020 | $250.5M+3% | SEC ↗ |
| Q2 2020 | Jul 13, 2020 | $243.1M+24% | SEC ↗ |
| Q1 2020 | Apr 10, 2020 | $196.4M−20% | SEC ↗ |
| Q4 2019 | Jan 9, 2020 | $244.1M+8% | SEC ↗ |
| Q3 2019 | Oct 11, 2019 | $225.8M+3% | SEC ↗ |
| Q2 2019 | Jul 10, 2019 | $220.1M+2% | SEC ↗ |
| Q1 2019 | Apr 8, 2019 | $215.0M+13% | SEC ↗ |
| Q4 2018 | Jan 15, 2019 | $191.0M−11% | SEC ↗ |
| Q3 2018 | Oct 15, 2018 | $215.4M+6% | SEC ↗ |
| Q2 2018 | Jul 17, 2018 | $202.3M+0% | SEC ↗ |
| Q1 2018 | Apr 16, 2018 | $201.4M+1% | SEC ↗ |
| Q4 2017 | Jan 12, 2018 | $200.2M+4% | SEC ↗ |
| Q3 2017 | Oct 13, 2017 | $192.6M+4% | SEC ↗ |
| Q2 2017 | Jul 10, 2017 | $185.8M+9% | SEC ↗ |
| Q1 2017 | Apr 11, 2017 | $170.1M+3% | SEC ↗ |
| Q4 2016 | Jan 10, 2017 | $164.8M+5% | SEC ↗ |
| Q3 2016 | Oct 11, 2016 | $157.7M+4% | SEC ↗ |
| Q2 2016 | Jul 8, 2016 | $151.6M+3% | SEC ↗ |
| Q1 2016 | Apr 15, 2016 | $147.0M | SEC ↗ |